BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
BHVN
Delisted
BHVN was delisted on the 3rd of October, 2022.
100 hedge funds and large institutions have $714M invested in Biohaven Pharmaceutical Holding Company Ltd. in 2018 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 51 increasing their positions, 18 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
11% more funds holding
Funds holding: 90 → 100 (+10)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
Holders
100
Holding in Top 10
5
Calls
$72.7M
Puts
$9.85M
Top Buyers
| 1 | +$64.9M | |
| 2 | +$62.2M | |
| 3 | +$18.9M | |
| 4 |
FCMI
Foresite Capital Management IV
Larkspur,
California
|
+$16.4M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$14.5M |
Top Sellers
| 1 | -$42.1M | |
| 2 | -$13.6M | |
| 3 | -$13.5M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$10.1M |
| 5 |
VMI
VHCP Management II
New York
|
-$8.45M |